The blend is positioned as a cost-effective alternative to traditional chemical improvers and emulsifiers, helping bakers transition to bromate-free production without sacrificing handling, consistency or product quality.
With improved first-half EBITA and strengthened leadership in the United States and Brazil, the company enters the second half of 2026 focused on operational execution, customer relationships, and continued expansion across specialty chemicals and ingredients markets.
Brenntag attributed the performance to coordinated pricing strategies and effective stocking decisions in North America and Europe, the Middle East and Africa.
The project is designed to expand the mill’s grain storage volume, improve lot segregation, and enhance blend preparation ahead of milling, thereby strengthening Molini Valente’s ability to produce consistent, high-quality flours for diverse bakery applications.
The deal builds on Novonesis’ original 2013 investment in MicroBioGen and its current 23% stake in the Sydney-based firm, extending a collaboration between the two companies that spans more than a decade.